Aktuellt
SENASTE
Despite pandemic headwinds, SyntheticMR delivered a record-strong quarter, to us signalling an inflection point. As such, the company has entered 2021 with newfound confidence and several pockets of growth. With clear evidence that recent improvement measures are taking effect, we argue a more positive stance on the medium-term potential is warranted. We derive a new DCF-based fair value range of SEK 391-516 per share.
LÄS MER
